PSMD4 and hepatocellular carcinoma: Moreover, introduction of p53 resensitize MCB1 overexpression hepatoma cells to CDDP treatment (Figure S7E,F, Supporting Information), which further suggesting that p53 was responsible for MCB1 mediated conventional chemoresistance.